162 related articles for article (PubMed ID: 36943159)
1. [Intoxications with synthetic cannabinoids].
Zanen JG; Leegwater E; Schippers EF; Wilms EB
Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36943159
[TBL] [Abstract][Full Text] [Related]
2. [Intoxications with synthetic cannabinoids].
Zanen JG; Leegwater E; Schippers EF; Wilms EB
Ned Tijdschr Geneeskd; 2023 Feb; 166():. PubMed ID: 36752668
[TBL] [Abstract][Full Text] [Related]
3. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
van Amsterdam J; Brunt T; van den Brink W
J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
[TBL] [Abstract][Full Text] [Related]
4. Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis.
Craft S; Ferris JA; Barratt MJ; Maier LJ; Lynskey MT; Winstock AR; Freeman TP
Psychopharmacology (Berl); 2022 May; 239(5):1349-1357. PubMed ID: 34533608
[TBL] [Abstract][Full Text] [Related]
5. Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans.
Santangelo O; Baldwin JM; Stogner J
Int J Drug Policy; 2022 Aug; 106():103756. PubMed ID: 35738030
[TBL] [Abstract][Full Text] [Related]
6. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
[TBL] [Abstract][Full Text] [Related]
7. Activity-based detection of synthetic cannabinoid receptor agonists in plant materials.
Timmerman A; Balcaen M; Coopman V; Degreef M; Pottie E; Stove CP
Harm Reduct J; 2024 Jul; 21(1):127. PubMed ID: 38951904
[TBL] [Abstract][Full Text] [Related]
8. Characterizing Trends in Synthetic Cannabinoid Receptor Agonist Use from Patient Clinical Evaluations during Medical Toxicology Consultation.
Tebo C; Mazer-Amirshahi M; Wax P; Campleman S; Boyer E; Brent J; Sheth A; Daniuaityte R; Carlson R
J Psychoactive Drugs; 2021; 53(3):207-214. PubMed ID: 33225872
[TBL] [Abstract][Full Text] [Related]
9. Involuntary MDMB-4en-PINACA intoxications following cannabis consumption: clinical and analytical findings.
Goncalves R; Labadie M; Chouraqui S; Peyré A; Castaing N; Daveluy A; Molimard M
Clin Toxicol (Phila); 2022 Apr; 60(4):458-463. PubMed ID: 34850659
[TBL] [Abstract][Full Text] [Related]
10. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins.
Banister SD; Connor M
Handb Exp Pharmacol; 2018; 252():165-190. PubMed ID: 29980914
[TBL] [Abstract][Full Text] [Related]
11. Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose.
Zaurova M; Hoffman RS; Vlahov D; Manini AF
J Med Toxicol; 2016 Dec; 12(4):335-340. PubMed ID: 27255136
[TBL] [Abstract][Full Text] [Related]
12. 'Synthetic cannabis': A dangerous misnomer.
Darke S; Banister S; Farrell M; Duflou J; Lappin J
Int J Drug Policy; 2021 Dec; 98():103396. PubMed ID: 34343944
[TBL] [Abstract][Full Text] [Related]
13. The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients.
Jackson MA; Brown AL; Johnston J; Clancy R; McGregor I; Bruno R; Lintzeris N; Montebello M; Luksza J; Bowman J; Phung N; Allsop D; Dunlop AJ
J Cannabis Res; 2021 Jul; 3(1):33. PubMed ID: 34311790
[TBL] [Abstract][Full Text] [Related]
14. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
Grafinger KE; Cannaert A; Ametovski A; Sparkes E; Cairns E; Banister SD; Auwärter V; Stove CP
Drug Test Anal; 2021 Jul; 13(7):1402-1411. PubMed ID: 33769699
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists.
Sachdev S; Banister SD; Santiago M; Bladen C; Kassiou M; Connor M
Pharmacol Res Perspect; 2020 Apr; 8(2):e00566. PubMed ID: 32101383
[TBL] [Abstract][Full Text] [Related]
16. Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights.
Malaca S; Busardò FP; Nittari G; Sirignano A; Ricci G
Curr Pharm Des; 2022; 28(32):2603-2617. PubMed ID: 34781870
[TBL] [Abstract][Full Text] [Related]
17. Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services.
Oomen PE; Schori D; Tögel-Lins K; Acreman D; Chenorhokian S; Luf A; Karden A; Paulos C; Fornero E; Gerace E; Koning RPJ; Galindo L; Smit-Rigter LA; Measham F; Ventura M
Int J Drug Policy; 2022 Feb; 100():103493. PubMed ID: 34687992
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
19. Synthetic Cannabinoid-Related Deaths in England, 2012-2019.
Yoganathan P; Claridge H; Chester L; Englund A; Kalk NJ; Copeland CS
Cannabis Cannabinoid Res; 2022 Aug; 7(4):516-525. PubMed ID: 33998886
[No Abstract] [Full Text] [Related]
20. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.
Gamage TF; Barrus DG; Kevin RC; Finlay DB; Lefever TW; Patel PR; Grabenauer MA; Glass M; McGregor IS; Wiley JL; Thomas BF
Pharmacol Biochem Behav; 2020 Jun; 193():172918. PubMed ID: 32247816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
